1 |
Chambers LM, Yao M, Morton M, Gruner M, Chichura A, Costales AB, Horowitz M, Rose PG, Michener CM, Debernardo R. Assessment of Travel Distance for Hyperthermic Intraperitoneal Chemotherapy in Women with Ovarian Cancer. Gynecologic Oncology Reports 2022. [DOI: 10.1016/j.gore.2022.100951] [Reference Citation Analysis]
|
2 |
Chambers LM, Chalif J, Yao M, Chichura A, Morton M, Gruner M, Costales AB, Horowitz M, Chau DB, Vargas R, Rose PG, Michener CM, Debernardo R. Modified frailty index predicts postoperative complications in women with gynecologic cancer undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Gynecol Oncol 2021;162:368-74. [PMID: 34083027 DOI: 10.1016/j.ygyno.2021.05.013] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
3 |
Gruner M, Chambers LM, Yao M, Chichura A, Morton M, Costales AB, Horowitz M, Rose PG, Debernardo R, Michener CM. Anastomotic leak following interval debulking surgery with or without hyperthermic intraperitoneal chemotherapy in women with advanced epithelial ovarian Cancer. Gynecol Oncol 2021;162:645-51. [PMID: 34247768 DOI: 10.1016/j.ygyno.2021.06.034] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|